📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
232 analysed today
FollowTelegram
232
Today
149,633
All-time analysed
42,906
Positive
6,661
Negative
91,389
Neutral
8,609
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
55 announcements match the current filters (relevance ≥ 5).
Shree Pushkar Reports FY26 Revenue Growth of 21% to Rs 976.6 Cr, PAT Up 20%
Shree Pushkar Chemicals & Fertilisers Limited reported a strong full-year performance for FY26, with revenue from operations growing 21.1% YoY to Rs 976.6 crore. Full-year EBITDA increased by 18.7% to Rs 99.5 crore, while PAT grew 19.6% to Rs 70.1 crore. However, Q4 FY26 revenue was flat at Rs 218.2 crore, and Q4 PAT declined 22.2% YoY to Rs 12.9 crore due to global supply chain disruptions. The company is actively expanding its capacities across both chemical and fertiliser segments, funded via internal accruals and preferential issues.
Key Highlights
FY26 Revenue from Operations increased by 21.1% YoY to Rs 976.6 crore compared to Rs 806.3 crore in FY25.
FY26 PAT grew by 19.6% YoY to Rs 70.1 crore, with Return on Equity (ROE) improving to 12.2%.
Q4 FY26 performance was softer with Revenue down 0.6% YoY to Rs 218.2 crore and PAT down 22.2% YoY to Rs 12.9 crore.
The company maintains a strong capital structure with a negative Net Debt/Equity ratio of (0.01)x and Rs 140.68 crore in non-lien deposits.
Ongoing expansions aim to increase fertiliser capacity by 4,50,000 MTPA and chemical capacity by 72,000 MTPA.
👀 What to Watch
Investors should look past the short-term Q4 slowdown caused by global supply chain issues and focus on the strong full-year growth and upcoming capacity expansions. The company's zero-waste integrated model and virtually debt-free balance sheet make it a strong long-term bet in the chemical and fertiliser space.
Shree Pushkar FY26 PAT Grows 19.6% to ₹70.1 Cr; Q4 Performance Muted by Supply Chain Issues
Shree Pushkar reported a robust full-year performance for FY26 with revenue growing 21.1% to ₹976.6 crore and PAT increasing 19.6% to ₹70.1 crore. However, the fourth quarter (Q4 FY26) was significantly weaker, with PAT dropping 22.2% YoY to ₹12.9 crore due to global supply chain disruptions. The company maintains a very strong balance sheet with a negative net debt-to-equity ratio of -0.01x and ₹140.7 crore in non-lien deposits. While chemical volumes grew 27.9% for the full year, fertiliser volumes saw a slight decline of 3%.
Key Highlights
FY26 Revenue from Operations increased by 21.1% YoY to ₹976.6 Crores.
Full-year PAT grew by 19.6% to ₹70.1 Crores with an EPS of ₹21.6.
Q4 FY26 PAT fell 22.2% YoY and 28.8% QoQ to ₹12.9 Crores, reflecting margin pressure.
Chemical segment volumes grew 27.9% in FY26, reaching 72,423 MT.
Company maintains a net-debt free status with a Net Debt/EBITDA of -0.05x.
👀 What to Watch
Investors should monitor the recovery of margins in the upcoming quarters and the commissioning of Ratnagiri Unit 5 and 6, which have faced external delays. The strong balance sheet and full-year growth are positive, but the sharp sequential decline in Q4 earnings warrants a cautious watch on near-term headwinds.
Shree Pushkar Chemicals Recommends ₹2.10 Final Dividend for FY26
Shree Pushkar Chemicals & Fertilisers has recommended a final dividend of ₹2.10 per share for the financial year ended March 31, 2026. This represents a 21% payout on the face value of ₹10 per share, subject to shareholder approval at the upcoming Annual General Meeting. Along with the dividend, the company approved its audited annual financial results for FY26 with an unmodified audit opinion. The board also confirmed the re-appointment of RMJ & Associates LLP as internal auditors for the 2026-27 fiscal year.
Key Highlights
Recommended a final dividend of ₹2.10 per equity share (21% of face value of ₹10).
Approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026.
Statutory auditors issued an unmodified audit report for the full financial year.
Re-appointed M/s. RMJ & Associates LLP as Internal Auditors for FY 2026-2027.
Consolidated results now include new subsidiaries Dyecol Color Technologies and Dyecol Bangladesh.
👀 What to Watch
Investors should track the upcoming AGM date and record date to ensure eligibility for the ₹2.10 dividend. The unmodified audit report and dividend recommendation suggest stable financial health, but investors should review the detailed FY26 earnings for growth trends in the chemicals and fertilizer segments.
Shree Pushkar Chemicals FY26 Results: Board Recommends Rs 2.10 Dividend Per Share
Shree Pushkar Chemicals & Fertilisers has reported its audited financial results for the fiscal year ended March 31, 2026, alongside a dividend recommendation of Rs 2.10 per share (21%). The company's consolidated performance now accounts for new subsidiaries, Dyecol Color Technologies and Dyecol Bangladesh, which were added during the fiscal year. The statutory auditors have issued an unmodified opinion, confirming the reliability of the financial disclosures. Additionally, the board has re-appointed internal auditors for the 2026-27 period to maintain corporate governance standards.
Key Highlights
Recommended a dividend of Rs 2.10 per equity share (21% of face value) for FY 2025-26.
Consolidated results now include Dyecol Color Technologies (w.e.f. Sept 2025) and Dyecol Bangladesh (w.e.f. Nov 2025).
Statutory auditors issued an unmodified audit report for both standalone and consolidated financial results.
Re-appointed M/s. RMJ & Associates LLP as Internal Auditors for the 2026-27 financial year.
👀 What to Watch
The dividend recommendation indicates healthy cash flows; investors should review the detailed profit and loss statement to assess the margin contribution from the newly added subsidiaries.
S H Kelkar Reports FY26 Revenue Up 11.5% to Rs 2,368 Cr; EBITDA Margins Under Pressure
S H Kelkar and Company Limited (SHK) reported an 11.5% year-on-year growth in revenue from operations to Rs 2,368 crore for FY2026, up from Rs 2,123 crore in FY2025. However, Adjusted EBITDA for the full year saw a slight decline to Rs 323 crore compared to Rs 335 crore in the previous year, with margins contracting from 15.9% to 13.9%. For Q4 FY26, revenue increased by 14.6% to Rs 650 crore, while Adjusted EBITDA remained flat at Rs 83 crore. The management highlighted rising raw material prices due to Middle East geopolitical tensions, which could impact margins in upcoming quarters.
Key Highlights
FY2026 revenue from operations increased by 11.5% YoY to Rs 2,368 crore.
FY2026 Adjusted EBITDA margin compressed to 13.9% from 15.9% in FY2025.
Q4 FY2026 revenue grew 14.6% YoY to Rs 650 crore, including a one-off portfolio optimization sale of Rs 35 crore.
Fragrance segment revenue grew 10.4% to Rs 2,052 crore in FY26, while Flavour segment grew 29.6% to Rs 240 crore.
Management warns of potential margin pressure in coming quarters due to rising raw material costs, despite current inventory coverage.
👀 What to Watch
Investors should monitor the company's ability to pass on rising raw material costs through pricing measures in the coming quarters. While top-line growth remains healthy across segments, the pressure on EBITDA margins warrants a cautious approach.
SHK FY26 Revenue Up 11.5% to Rs 2,368 Cr; Adjusted EBITDA Margins Contract to 13.9%
S H Kelkar (SHK) reported a steady 11.5% YoY revenue growth for FY26, reaching Rs 2,368 crore, driven by robust performance in the Flavour segment which grew 29.6%. However, Adjusted EBITDA margins for the full year contracted to 13.9% from 15.9% in FY25 due to rising raw material costs and geopolitical dynamics. Q4 FY26 revenue also showed strength, rising 14.6% YoY to Rs 650 crore, though this included a one-off portfolio optimization sale of Rs 35 crore. Management is focusing on pricing measures and debt reduction to counter potential margin pressure from rising commodity prices in the coming quarters.
Key Highlights
FY26 Revenue from operations increased 11.5% YoY to Rs 2,368 crore, with Flavour segment growing 29.6%.
Adjusted EBITDA for FY26 stood at Rs 323 crore with a margin of 13.9%, down from 15.9% in the previous year.
Q4 FY26 Revenue grew 14.6% YoY to Rs 650 crore, supported by steady demand in Fragrance and Flavour segments.
Management warned of potential margin impact in future quarters due to rising raw material prices linked to Middle East tensions.
The company is prioritizing financial discipline with a focus on debt reduction and improving the cash conversion cycle.
👀 What to Watch
Investors should monitor the company's ability to implement pricing hikes to offset rising raw material costs. While top-line growth is healthy, the contraction in margins suggests a need for caution until cost pressures stabilize.
SHK Appoints B S R & Co. LLP as Statutory Auditors for 5 Years; FY26 Results Approved
S H Kelkar and Company Limited (SHK) has approved its audited financial results for the fiscal year ended March 31, 2026, with current auditors Deloitte issuing an unmodified opinion. The Board has recommended the appointment of B S R & Co. LLP as the new Statutory Auditors for a five-year term starting from the 70th AGM until 2031. Additionally, Ernst & Young LLP has been appointed as Internal Auditors for FY 2026-27. These changes in audit firms represent a move towards top-tier professional services for corporate governance.
Key Highlights
Board approved audited standalone and consolidated financial results for the year ended March 31, 2026
Proposed appointment of B S R & Co. LLP as Statutory Auditors for a 5-year term until 2031
Ernst & Young LLP appointed as Internal Auditors for the financial year 2026-27
Deloitte Haskins and Sells LLP issued an unmodified audit opinion for the FY26 results
70th Annual General Meeting (AGM) scheduled for July 31, 2026
👀 What to Watch
Investors should review the detailed FY26 financial performance once the full report is available. The transition to B S R & Co. LLP and E&Y for audit functions is a positive indicator of institutional-grade governance.
SHK Approves FY26 Results; Appoints B S R & Co. LLP as Statutory Auditors for 5 Years
S H Kelkar and Company Limited (SHK) has approved its audited financial results for the quarter and fiscal year ended March 31, 2026, with current auditors Deloitte issuing an unmodified opinion. A significant governance update includes the proposed appointment of B S R & Co. LLP as Statutory Auditors for a five-year term from 2026 to 2031. The company also appointed Ernst & Young LLP as Internal Auditors and Kishore Bhatia & Associates as Cost Auditors for FY 2026-27. The 70th Annual General Meeting is scheduled for July 31, 2026.
Key Highlights
Approved audited standalone and consolidated financial results for the year ended March 31, 2026
Proposed B S R & Co. LLP as Statutory Auditors for a 5-year term until 2031
Appointed Ernst & Young LLP as Internal Auditors for the financial year 2026-27
Confirmed the 70th Annual General Meeting (AGM) will be held on July 31, 2026
Statutory Auditors Deloitte Haskins and Sells LLP issued an unmodified audit opinion
👀 What to Watch
Investors should examine the detailed financial statements for FY26 to evaluate the company's growth trajectory and margin performance. The shift to B S R & Co. LLP as statutory auditors is a positive step for long-term corporate governance and transparency.
SHK Appoints EY as Internal Auditors and BSR as Statutory Auditors; Approves FY26 Results
S H Kelkar and Company Limited (SHK) has approved its audited financial results for the fiscal year ended March 31, 2026, with an unmodified audit opinion from Deloitte. The board has appointed Ernst & Young LLP as Internal Auditors and Kishore Bhatia & Associates as Cost Auditors for FY 2026-27. Additionally, B S R & Co. LLP is proposed as the new Statutory Auditor for a five-year term (2026-2031), subject to shareholder approval. The 70th Annual General Meeting is scheduled for July 31, 2026.
Key Highlights
Approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026
Appointed Ernst & Young LLP (EY) as Internal Auditors for the financial year 2026-27
Proposed B S R & Co. LLP as Statutory Auditors for a 5-year term until the conclusion of the 75th AGM in 2031
Statutory Auditors issued an unmodified opinion on the financial results for the year ended March 31, 2026
The 70th Annual General Meeting (AGM) is set to be held on July 31, 2026
👀 What to Watch
Investors should review the full FY26 financial statements to assess the company's operational performance. The transition to Tier-1 audit firms like EY and BSR is a positive signal for corporate governance and internal controls.
SHK Approves FY26 Audited Results; Appoints B S R & Co. LLP as Statutory Auditors
S H Kelkar and Company Limited (SHK) has approved its audited standalone and consolidated financial results for the fiscal year ended March 31, 2026. The statutory auditors, Deloitte Haskins and Sells LLP, issued an unmodified opinion on these results. A significant change in governance includes the proposed appointment of B S R & Co. LLP as the new Statutory Auditors for a five-year term starting from the 70th AGM. Additionally, Ernst & Young LLP has been appointed as the Internal Auditors for the upcoming financial year 2026-27.
Key Highlights
Audited financial results for Q4 and FY26 approved with an unmodified audit opinion from Deloitte.
B S R & Co. LLP appointed as Statutory Auditors for a 5-year term from 2026 to 2031.
Ernst & Young LLP appointed as Internal Auditors for the financial year 2026-27.
70th Annual General Meeting (AGM) scheduled to be held on July 31, 2026.
Kishore Bhatia & Associates appointed as Cost Auditors for the financial year 2026-27.
👀 What to Watch
Investors should monitor the detailed financial performance metrics in the full earnings report to assess growth trends. The transition to B S R & Co. LLP as statutory auditors is a positive step in maintaining high-quality corporate governance.
SHK Approves FY26 Audited Results; Appoints B S R & Co. LLP as Statutory Auditors
S H Kelkar and Company Limited (SHK) has approved its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The board has proposed the appointment of B S R & Co. LLP as the new Statutory Auditors for a five-year term, subject to shareholder approval. Additionally, Ernst & Young LLP (EY) has been appointed as the Internal Auditors for FY 2026-27. The company's 70th Annual General Meeting is scheduled for July 31, 2026.
Key Highlights
Approved audited standalone and consolidated financial results for the fiscal year ended March 31, 2026.
Proposed appointment of B S R & Co. LLP as Statutory Auditors for a 5-year term (2026-2031).
Appointed Ernst & Young LLP (EY) as Internal Auditors for the financial year 2026-27.
The 70th Annual General Meeting (AGM) is scheduled to be held on July 31, 2026.
Current auditors Deloitte Haskins and Sells LLP issued an unmodified opinion on the FY26 financial statements.
👀 What to Watch
Investors should review the detailed financial statements for FY26 to evaluate the company's growth trajectory. The transition to top-tier audit firms like BSR and EY is a positive indicator of strengthening corporate governance.
SHK Approves FY26 Results; Appoints B S R & Co. as Statutory Auditors for 5-Year Term
S H Kelkar and Company (SHK) has approved its audited financial results for the quarter and fiscal year ended March 31, 2026. The company is strengthening its governance by proposing B S R & Co. LLP as the new statutory auditors for a five-year term and appointing Ernst & Young LLP as internal auditors for FY 2026-27. Current auditors Deloitte have issued an unmodified opinion, confirming the reliability of the financial statements. The 70th Annual General Meeting is scheduled for July 31, 2026.
Key Highlights
Approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.
Statutory auditors Deloitte issued an unmodified opinion on the financial results for FY 2026.
Proposed appointment of B S R & Co. LLP as Statutory Auditors for a 5-year term until 2031.
Appointed Ernst & Young LLP as Internal Auditors for the financial year 2026-27.
Scheduled the 70th Annual General Meeting (AGM) for July 31, 2026.
👀 What to Watch
Investors should review the detailed P&L and balance sheet once the full report is available to assess operational performance. The transition to Tier-1 audit firms like B S R & Co. and E&Y is a positive indicator of corporate governance standards.
SHK Q4 FY26 Update: Annual Revenue Grows 11.5% to Rs 2,355 Crore
S H Kelkar (SHK) reported a consolidated revenue of Rs 2,355 crore for FY 2025-26, marking a healthy 11.5% growth over the previous year. Despite geopolitical tensions in the Middle East and inflationary pressures, the company maintained stable gross margins on a sequential basis. Net debt stood at Rs 789 crore as of March 31, 2026, reflecting ongoing investments in capacity expansion. The company has successfully optimized inventory levels while maintaining strategic buffers for critical commodities impacted by supply chain disruptions.
Key Highlights
Consolidated FY26 revenue reached Rs 2,355 crore, representing approximately 11.5% YoY growth
Gross margins remained stable on a sequential basis during Q4 FY26
Net debt reported at Rs 789 crore, attributed to capital expenditure for capacity and capability building
Overall inventory levels reduced while maintaining coverage for commodities affected by Middle East crisis
Company remains focused on value-accretive growth despite fluid geopolitical and inflationary environments
👀 What to Watch
Investors should view the double-digit revenue growth as a positive sign of market share gains, but should monitor the debt levels and the impact of raw material inflation in the final audited results. The stock remains a watch for margin sustainability in the face of global supply chain volatility.
SHK to Sell 17% Stake in CFF Keva Italy to Subsidiary for up to €12.5 Million
S H Kelkar (SHK) is streamlining its European corporate structure by selling its direct 17% equity stake in CFF Keva Italy S.p.A. to its wholly-owned subsidiary, Keva Italy Srl. The transaction, valued at up to Euro 12.5 Million, will result in CFF becoming a 100% subsidiary of Keva Italy Srl. CFF is a significant contributor to the group, accounting for 16.86% of consolidated revenue (Rs. 358.04 Crores) and 7.42% of consolidated net worth in FY25. The restructuring is expected to be completed by September 30, 2026.
Key Highlights
Sale of 17% direct stake in CFF Keva Italy S.p.A. to wholly-owned subsidiary Keva Italy Srl.
Transaction consideration is valued at up to Euro 12.5 Million.
CFF Keva Italy contributed Rs. 358.04 Crores (16.86%) to FY25 consolidated revenue.
Post-sale, CFF will become a 100% subsidiary of Keva Italy Srl and an indirect subsidiary of SHK.
The move aims to consolidate all European group companies under Keva Europe BV.
👀 What to Watch
This is an internal restructuring and does not change the consolidated financials of the company. Investors should view this as a routine administrative move to simplify the international holding structure.
SHK to Sell 17% Stake in CFF Keva Italy to Subsidiary for Up to €12.5 Million
S H Kelkar and Company Limited (SHK) has approved the sale of its direct 17% equity stake in CFF Keva Italy S.p.A. to its wholly-owned subsidiary, Keva Italy Srl. The transaction, valued at up to €12.5 million, is an internal restructuring aimed at consolidating all European operations under Keva Europe BV. CFF Keva Italy is a significant unit, contributing approximately 16.86% to the company's consolidated revenue in FY25. The deal is expected to be completed by September 30, 2026, resulting in CFF becoming a 100% step-down subsidiary of SHK.
Key Highlights
Sale of 17% direct stake in CFF Keva Italy to subsidiary Keva Italy Srl for up to €12.5 million
CFF Keva Italy contributed ₹358.04 crore (16.86%) to consolidated revenue in FY25
Internal restructuring to streamline European operations under Keva Europe BV
CFF Keva Italy's net worth stood at ₹94.35 crore, representing 7.42% of consolidated net worth
Transaction expected to be completed on or before September 30, 2026
👀 What to Watch
This is a structural cleanup and does not change the ultimate consolidated ownership of the Italian business. Investors should view this as a routine administrative move to simplify the international holding structure.
SHK Reports FY25 Total Income of ₹2,147 Cr; Expands Global Footprint with New CDCs
S H Kelkar (SHK) reported a total income of ₹2,147 crore and a cash profit of ₹224 crore for FY25, maintaining a 5-year CAGR of approximately 10%. As the largest Indian-origin Fragrance & Flavour company, SHK serves over 4,100 customers with a portfolio of 9,700+ products across 4 continents. The company is aggressively expanding its global presence, recently establishing new Creation and Development Centres in the USA, Germany, and the UK in 2025. With a CRISIL AA- rating and a library of 50,000+ proprietary recipes, SHK is well-positioned to capture growth in the evolving global F&F market.
Key Highlights
Reported FY25 Total Income of ₹2,147 crore with a cash profit of ₹224 crore
Maintained a steady 5-year Total Income CAGR of ~10% between FY2021 and FY2025
Expanded global footprint in 2025 with new CDCs in New Jersey, Hamburg, and Manchester
Serves a diverse base of 4,100+ customers globally with a library of 50,000+ proprietary recipes
Maintains a strong credit profile with a CRISIL AA-/Stable rating on long-term bank facilities
👀 What to Watch
Investors should monitor SHK's ability to scale its new international centres and leverage its proprietary molecule library for higher margins. The stock remains a key play on the FMCG and premiumization trend in India and emerging markets.
Shree Pushkar Q3 FY26 Revenue Up 14.6% to ₹249 Cr; PAT Rises 13.5% to ₹18 Cr
Shree Pushkar Chemicals reported a 14.6% YoY revenue growth to ₹249 crores in Q3 FY26, led by a 38.1% increase in the chemical segment. Net profit grew 13.5% to ₹18 crores, although EBITDA margins softened to 8.9% due to doubling sulphur costs. The company remains debt-free with ₹176.75 crores in cash and is expanding its solar capacity to 20.6 MW. Promoters infused ₹30 crores via preferential allotment, signaling long-term confidence.
Key Highlights
Q3 FY26 revenue reached ₹249 crores, up 14.6% YoY, while 9M FY26 PAT surged 36% to ₹57 crores.
Chemical segment volumes grew 75.6% YoY, though fertilizer revenue fell 10.6% due to seasonal factors and high input costs.
Gross margins declined to 31.9% from 35.7% YoY as sulphur prices spiked from ~$280 to ~$560 per ton.
Unit 5 expansion is ready for trial production, pending an electricity connection expected in February 2026.
Maintained a strong cash position with ₹176.75 crores in deposits and zero external debt.
👀 What to Watch
Investors should monitor the commissioning of Unit 5 and the trend in sulphur prices, as these will be the primary drivers for near-term margin expansion. The company's debt-free status and promoter funding provide a high safety margin for long-term investors.
SH Kelkar Q3 FY26: 9M Revenue Grows 10% to Rs 1,718 Cr; US Market Entry Gains Traction
S H Kelkar reported a 10% YoY revenue growth for the first nine months of FY26, reaching Rs 1,718 crore despite a challenging global environment. The company is aggressively investing in international markets like the US, UK, and Europe, which represent 75% of the global fragrance market compared to India's 5%. While EBITDA margins were impacted by these growth-led investments, adjusted margins stood at 13%. A significant milestone was achieved with the first customer order in the US market, signaling the start of a long-term organic build-out strategy.
Key Highlights
9M FY26 consolidated revenue reached Rs 1,718 crore, reflecting a 10% year-on-year growth.
Adjusted EBITDA margin stood at approximately 13% after excluding strategic growth investments and insurance costs.
Gross margins were stable at 42.4%, with management expecting improvement starting from the Jan-March quarter.
The US Creative Development Centre secured its first customer order, marking a key entry into the world's largest fragrance market.
Management indicated that debt levels may see a near-term increase to fund strategic initiatives and capacity expansion.
👀 What to Watch
Investors should monitor the company's ability to translate international investments into bottom-line growth and watch for the promised gross margin recovery in Q4. The stock remains a long-term play on global market share expansion, though near-term leverage and investment costs are key risks.
Shree Pushkar Reports 14.6% YoY Revenue Growth in Q3 FY26; PAT Up 13.5% to ₹18.1 Cr
Shree Pushkar Chemicals & Fertilisers reported a 14.6% YoY increase in Q3 FY26 revenue to ₹249 Cr, primarily driven by a 38.1% growth in the Chemicals segment. While PAT rose 13.5% to ₹18.1 Cr, EBITDA margins contracted to 8.9% from 10.3% in the previous year's quarter. The company is executing a massive ₹541 Cr capex plan, with Ratnagiri Units 5 and 6 scheduled for commissioning in Q4 FY26. Additionally, the company has expanded its international footprint by incorporating a subsidiary in Bangladesh.
Key Highlights
9M FY26 Revenue grew by 29.2% YoY to ₹759 Cr, with PAT increasing 36% to ₹57.2 Cr.
Chemicals segment volume surged 75.6% YoY in Q3 FY26, contributing 63% of total revenue.
Total planned capex of ₹541 Cr to add 4.5 lakh MTPA fertiliser and 72,000 MTPA chemical capacity.
Solar power capacity is being expanded from 9.5 MWDC to 20.6 MWDC for energy self-reliance.
Ratnagiri Unit 5 and Unit 6 expansions are on track for commissioning by the end of Q4 FY26.
👀 What to Watch
Investors should focus on the upcoming commissioning of the Ratnagiri units in Q4 FY26, which is expected to boost volumes. The promoter's continued participation in preferential allotments indicates strong internal confidence in the long-term growth strategy.
Shree Pushkar Q3 FY26 Revenue up 14.6% YoY to ₹248.9 Cr; PAT rises 13.5% to ₹18.1 Cr
Shree Pushkar Chemicals & Fertilisers reported a steady Q3 FY26 with consolidated revenue growing 14.6% YoY to ₹248.9 Cr, though EBITDA margins contracted to 8.9% from 10.3% YoY. The Chemical segment performed strongly with a 38.1% revenue jump, effectively offsetting a 10.6% decline in the Fertiliser segment. For the nine-month period (9M FY26), the company showed robust growth with revenue and PAT increasing by 29.2% and 36.0% respectively. Key growth catalysts include the upcoming commissioning of Ratnagiri units in Q4 FY26 and a significant expansion in solar capacity to 20.6 MWDC.
Key Highlights
Q3 FY26 Revenue grew 14.6% YoY to ₹248.9 Cr, while PAT increased 13.5% YoY to ₹18.1 Cr.
Chemical segment revenue surged 38.1% YoY to ₹156 Cr, driven by a 75.6% increase in sales volumes.
Fertiliser segment revenue declined 10.6% YoY to ₹93 Cr with volumes falling 23.7% during the quarter.
Ratnagiri Unit 5 and Unit 6 are scheduled for commissioning in Q4 FY26, providing a clear growth roadmap.
Solar power capacity is being expanded from 9.5 MWDC to 20.6 MWDC to improve energy self-reliance and sustainability.
👀 What to Watch
Investors should monitor the successful commissioning of the Ratnagiri units in Q4 FY26 as they are critical for the next phase of growth. While Q3 margins saw some pressure, the strong 9M performance and promoter confidence via preferential allotment suggest long-term stability.
